Hypotensive therapy in stroke survivors.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000578:Amidines / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D005260:Female; D005500:Follow-Up Studies; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007546:Isoquinolines / Q000627:therapeutic use; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged
D000578:Amidines; D000959:Antihypertensive Agents; D006146:Guanidines; D007546:Isoquinolines; D008750:Methyldopa